Comments
Loading...

Mersana Therapeutics

MRSNNASDAQ
Logo brought to you by Benzinga Data
$2.12
00.00%
Pre-Market: 5:41 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$14.00
Lowest Price Target1
$1.00
Consensus Price Target1
$6.38

Mersana Therapeutics (NASDAQ:MRSN) Stock, Analyst Ratings, Price Targets, Forecasts

Mersana Therapeutics Inc has a consensus price target of $6.38 based on the ratings of 8 analysts. The high is $14 issued by SVB Leerink on August 9, 2022. The low is $1 issued by Citigroup on July 28, 2023. The 3 most-recent analyst ratings were released by Citigroup, Baird, and JP Morgan on August 27, 2024, August 14, 2024, and March 19, 2024, respectively. With an average price target of $4.33 between Citigroup, Baird, and JP Morgan, there's an implied 104.40% upside for Mersana Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Citigroup
Baird
JP Morgan
Wedbush
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Mersana Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Mersana Therapeutics (MRSN) stock?

A

The latest price target for Mersana Therapeutics (NASDAQ:MRSN) was reported by Citigroup on August 27, 2024. The analyst firm set a price target for $5.00 expecting MRSN to rise to within 12 months (a possible 135.85% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Mersana Therapeutics (MRSN)?

A

The latest analyst rating for Mersana Therapeutics (NASDAQ:MRSN) was provided by Citigroup, and Mersana Therapeutics maintained their buy rating.

Q

When was the last upgrade for Mersana Therapeutics (MRSN)?

A

The last upgrade for Mersana Therapeutics Inc happened on March 19, 2024 when JP Morgan raised their price target to $5. JP Morgan previously had an underweight for Mersana Therapeutics Inc.

Q

When was the last downgrade for Mersana Therapeutics (MRSN)?

A

The last downgrade for Mersana Therapeutics Inc happened on July 28, 2023 when Citigroup changed their price target from $10 to $1 for Mersana Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for Mersana Therapeutics (MRSN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mersana Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mersana Therapeutics was filed on August 27, 2024 so you should expect the next rating to be made available sometime around August 27, 2025.

Q

Is the Analyst Rating Mersana Therapeutics (MRSN) correct?

A

While ratings are subjective and will change, the latest Mersana Therapeutics (MRSN) rating was a maintained with a price target of $6.00 to $5.00. The current price Mersana Therapeutics (MRSN) is trading at is $2.12, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch